Dear Valued Customers
As COVID-19 (Coronavirus) spread escalates globally, I wanted to reach out and let you know how Amsino is handling this unprecedented crisis. We at Amsino are committed to the continuity of serving our customers, while at the same time ensuring the health and wellness of our employees.
On January 28, 2020, we established a COVID-19 task force. We have since put many precautionary measures into action aiming at protecting our employees and minimizing the impact on our customers.
Posted: March 1, 2020 | Press
AMSINO CHINA DONATES 1 MILLION RMB IN MEDICAL PRODUCTS TO HELP FIGHT AGAINST CORONAVIRUS
FIGHT AGAINST CORONAVIRUS, AMSINO IN ACTION
Since the beginning of the COVID-19 viral outbreak, Amsino has actively joined in the fight against the coronavirus outbreak. Upholding its strong sense of social responsibilities and professionalism, Amsino has donated 1 million RMB in medical products directly to many hospitals in Wuhan, Hubei Province, Shanghai, and Jiangsu areas.
AMSINO - Contributing to China’s Healthcare Industry Upgrading
Interview with Dr. Richard Y. Lee, Founder, Chairman & CEO of Amsino Medical Group
Dr. Richard Y. Lee, Founder, Chairman and CEO Amsino Medical Group, told the journalist that AMSINO was founded in 1993 and headquartered in California as a multinational medical device company that integrates R&D, manufacturing and global sales and marketing. It has 2000 employees working in 6 business divisions and 5 factories. Amsino Medical Group is aimed to improve healthcare by enhancing the safety and efficacy of patient care. It has obtained over 100 patents of internationally leading medical technologies. AMSINO medical products mainly cover: medication delivery systems, enteral nutrition feeding systems, RECEPTAL and iRECEPTAL waste fluid management systems, urological care, respiratory therapy systems, and surgical and nursing solutions. AMSINO medical products are distributed in more than 80 countries around the world besides the US. He said, "This year marks the 25th anniversary of the founding of AMSINO. Our company has undergone great changes in R&D, manufacturing and globalization. We have six business divisions, which are North America Business Division, Latin America Business Division, Europe, Middle East and Africa Business Division, Asia Pacific Business Division, China Business Division, and Contract Manufacturing Business Division. Among them, the US supports sales in North America and Latin America, Amsterdam of Netherlands supports sales in Europe, Middle East and Africa, and Shanghai of China supports sales in Asia Pacific, including Greater China Region. We attach great importance to the Chinese market which is a strategic market with unlimited business opportunities and great potential for growth. At present, our business in China accounts for about 15% of the total sales volume of the company."
AMSINO CLOSED THE ASSET PURCHASE AGREEMENT TO ACQUIRE SMITHS MEDICAL’S VERNON HILL’S PLANT
Pomona, CA —Amsino Medical Group is pleased to announce the closing of the previously announced Asset Purchase Agreement today with Smiths Medical ASD, Inc. (Smiths) to acquire the assets of Smiths’ manufacturing plant located in Vernon Hills, Illinois (VH). The transaction includes all assets and infrastructure that currently exist in the facility.